TargetMol

M&B 4261

Product Code:
 
TAR-T33116
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33116-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33116-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
M&B 4261 is a bioactive chemical.
CAS:
4174-67-8
Molecular Weight:
532.47
Purity:
0.98
SMILES:
[Cl-].Cl.N=C(N)C1=CC=C(C=C1)NN=NC=2C=CC=3C=4C=CC(N)=CC4[N+](=C(C=5C=CC=CC5)C3C2)CC

References

Khachatryan V, Sirunyan AM, Tumasyan A, et al. Search for new physics in same-sign dilepton events in proton-proton collisions at [Formula: see text]. Eur Phys J C Part Fields. 2016;76(8):439. doi: 10.1140/epjc/s10052-016-4261-z. Epub 2016 Aug 5. PubMed PMID: 28303081; PubMed Central PMCID: PMC5331874. Wei M, Guan Q, Liang H, Chen J, Chen Z, Hei F, Feng Y, Hong K, Huang H, Xing H, Shao Y. Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC. J Clin Microbiol. 2004 Sep;42(9):4261-7. PubMed PMID: 15365021; PubMed Central PMCID: PMC516361. Milano F, Gerencs?r L, Agostiano A, Nagy L, Trotta M, Mar?ti P. Mechanism of quinol oxidation by ferricenium produced by light excitation in reaction centers of photosynthetic bacteria. J Phys Chem B. 2007 Apr 26;111(16):4261-70. Epub 2007 Mar 30. PubMed PMID: 17394306. Kishi T, Matsunaga S, Iwata N. The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis. Neuropsychiatr Dis Treat. 2017 Jul 20;13:1909-1928. doi: 10.2147/NDT.S142839. eCollection 2017. PubMed PMID: 28790827; PubMed Central PMCID: PMC5530072.